Eloralintide Phase 2 in Overweight/Obesity: Safety Evaluation

Authors
Category Primary study
Conference43rd Annual Meeting of the Obesity Society at Obesity Week
Year 2025
This article has no abstract
Epistemonikos ID: 756ff3de0ec2144909c8fa45247dd4cf2fb7aabd
First added on: Jan 31, 2026